Vancouver, Canada – April 25, 2025 – AI/ML Innovations Inc. (“AIML” or the “Company”) (CSE: AIML;OTCQB: AIMLF; FWB: 42FB) announces that Tim Daniels has stepped down from his position on the Company’s Board of Directors (“Board”), effective immediately.
Tim has been an integral part of AIML’s leadership, contributing to the Company’s strategic direction and governance during his tenure on the Board. His insights and dedication have played a key role in guiding AIML through important phases of growth and evolution.
Paul Duffy, CEO of AIML, commented:
“On behalf of the entire team at AIML, I would like to extend our sincere thanks to Tim for his contributions and leadership. We are pleased that Tim will continue to support the Company in an advisory capacity, where his experience and counsel will remain a valued asset as we advance our mission in AI-driven healthcare.”
AIML remains focused on strengthening its leadership and advisory network to support ongoing commercialization efforts and strategic growth initiatives.
For more information about AIML:
For detailedinformation please see AIML's website or the Company's filed documents at www.sedarplus.ca.
Contact:
Blake Fallis
(778) 405-0882
info@aiml-innovations.com
AboutAI/ML Innovations Inc. https://aiml-innovations.com/
AIML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through its wholly owned subsidiaries, NeuralCloud Solutions Inc. (theneuralcloud.com), Quantum Sciences Ltd, and AI Rx Inc., strategic partnerships with HealthGauge Inc. (95.2% owned by AIML), and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AIML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".
On behalf of the Board of Directors:
Paul Duffy, Chairman
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements – Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.
